BAT4306F
/ Bio-Thera Solutions
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 08, 2023
A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients
(clinicaltrials.gov)
- P1 | N=16 | Completed | Sponsor: Bio-Thera Solutions | Unknown status ➔ Completed | N=65 ➔ 16
Enrollment change • Trial completion • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD20
November 06, 2019
A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients
(clinicaltrials.gov)
- P1; N=65; Enrolling by invitation; Sponsor: Bio-Thera Solutions
Clinical • New P1 trial
1 to 2
Of
2
Go to page
1